Journals / Clinical and Experimental Health Sciences / 2018 / Cilt: 8 - Sayı: 3

Does Patient-Controlled Infraclavicular Perineural Dexmedetomidine Increase the Duration of Postoperative Analgesia?

Pages
154–159
Publication Date
2018-09-28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

None of the patients developed sedation/neurological deficits.Conclusion: Perineural infusion of dexmedetomidine combined with bupivacainewas found to increase the duration of postoperative analgesia, reduce 24-hour need for analgesia and have not any adverse efect at low doses.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Peripheral nerve blocks are now used widely for postoperative analgesiaand peripheral nerve catheters are widely utilized.
📊
Key Findings & Data:Objective of this study was toinvestigate effect of perineural infusion of dexmedetomidine on the duration ofpostoperative analgesia retrospectively.Material & Methods: A total of 60 patients aged between 18 and 65 years wereincluded in the study.
💡
Conclusion & Impact:None of the patients developed sedation/neurological deficits.Conclusion: Perineural infusion of dexmedetomidine combined with bupivacainewas found to increase the duration of postoperative analgesia, reduce 24-hour need for analgesia and have not any adverse efect at low doses.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Patient-Controlled Analgesia · Perineural Dexmedetomidine infusion · Duration of Postoperative Analgesia

Abstract

Objective: Peripheral nerve blocks are now used widely for postoperative analgesiaand peripheral nerve catheters are widely utilized. Objective of this study was toinvestigate effect of perineural infusion of dexmedetomidine on the duration ofpostoperative analgesia retrospectively.Material & Methods: A total of 60 patients aged between 18 and 65 years wereincluded in the study. Group 1 received infraclavicular patient-controlled perineuralbupivacaine (0.1 %). Group 2 received infraclavicular patient-controlled perineuralbupivacaine (0.1 %) + dexmedetomidine (200 mic/100 cc). Blood pressure, pulse,peripheral oxygen saturation modified ramsay sedation scale, visual pain scores, totalamount of analgesics were recorded at the 0, 30, 60, 90 minutes and 2, 4, 6, 8, 12,24 hours.Results: Systolic blood pressure was higher in Group 1 at the hour 6 (p: 0.007).Whereas, diastolic blood pressure was higher in Group 1 at the hours 4 and 6 (p:0.000, p: 0.003). Heart rate was found to be higher in Group 2 at the hours 8, 12 and24 (p: 0.004, p: 0.002, p: 0.002). Patients in Group 1 were found to significantly feelpain and need analgesics at the hours 4 and 6 (p: 0.002, p< 0.05). The mean numberof patient requests for analgesia was 5.8±1.4 times in Group 1 and 2.2±0.4 in Group2 (p<0,05). None of the patients developed sedation/neurological deficits.Conclusion: Perineural infusion of dexmedetomidine combined with bupivacainewas found to increase the duration of postoperative analgesia, reduce 24-hour need for analgesia and have not any adverse efect at low doses.

🔖

Cite This Article

KUPELİ, İ., KUYRUKLUYILDIZ, U., TAŞ, S., BEDİR, Z., SELCAN, A. (2018). Does Patient-Controlled Infraclavicular Perineural Dexmedetomidine Increase the Duration of Postoperative Analgesia?. Clinical and Experimental Health Sciences, Cilt: 8 - Sayı: 3, 154–159. https://ajindex.com/articles/481704

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Liu SS. A comparison of regional versus general anesthesia for ambulatory anesthesia: a meta-analysis of randomized controlled trials. Anesth Analg 2005; 101: 1634–42.